Head-to-head · WeighScore
Strut Health vs Vea Health
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 55/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Strut Health | Vea Health |
|---|---|---|
| WeighScore | 79.4/100 | 55/100 |
| Grade | C+ | C |
| Site position | #28 | #499 |
| Semaglutide | Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal | Not disclosed |
| Tirzepatide | Oral $199/30 days; injection $219/mo—confirm prescribed dose, quantity and renewal | Not disclosed |
| Coverage | FAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #28 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
- Provider consultations, follow-ups and shipping are advertised as included
- Current help describes an account cancellation button; terms also provide an email route
- Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription
What to consider
- Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
- Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
- 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
- Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024
Site position #499 · C
Strengths
- Publishes the FDA compounded-medication disclaimer
- Oral and injection protocols for both semaglutide and tirzepatide
- Claims 50-state coverage via a clinician network
- Clearly differentiated positioning (longevity, men's health, performance)
What to consider
- Pricing not shown until after sign-up
- Pharmacy partner not named (only 'U.S.-based pharmacy')
- LegitScript certification status not visible
- No named medical director
- 503A vs 503B designation not specified
Featured provider
Strut Health
Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.